Higher frequency of hepatic steatosis at CT among COVID-19-positive patients.
Augusto Kreling MedeirosCinthia Callegari BarbisanItalo Ribeiro CruzEduardo Medeiros de AraújoBruna Brandão LibânioKamila Seidel AlbuquerqueUlysses Santos TorresPublished in: Abdominal radiology (New York) (2020)
A significantly higher prevalence of steatosis was found among COVID-19 positive individuals. These findings are in accordance with other recent studies linking obesity and COVID-19 infection, as there is an intricate relationship between liver steatosis, metabolic syndrome and obesity. Further studies are required to confirm if such association remains after accounting for multiple variables, as well as possible relationships with disease severity and worst clinical outcomes.
Keyphrases
- insulin resistance
- metabolic syndrome
- high fat diet induced
- coronavirus disease
- sars cov
- high fat diet
- end stage renal disease
- type diabetes
- weight loss
- adipose tissue
- newly diagnosed
- ejection fraction
- skeletal muscle
- chronic kidney disease
- weight gain
- case control
- respiratory syndrome coronavirus
- peritoneal dialysis
- prognostic factors
- magnetic resonance imaging
- patient reported outcomes
- magnetic resonance
- image quality
- physical activity